These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


451 related items for PubMed ID: 6999479

  • 1. Hypertension screening and treatment with angiotensin inhibitors. Saralasin and captopril.
    Zawada ET, Stinson J, Ramirez G.
    Postgrad Med; 1980 Oct; 68(4):89-92, 94-5, 98. PubMed ID: 6999479
    [Abstract] [Full Text] [Related]

  • 2. Use of angiotensin antagonists in experimental and human renovascular hypertension.
    Maxwell MH.
    Adv Nephrol Necker Hosp; 1979 Oct; 8():297-319. PubMed ID: 115245
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [The Saralasin test in the diagnosis of renovascular hypertension. Personal experience].
    Giuliani L, Martorana G, Giberti C.
    Minerva Nefrol; 1979 Oct; 26(4):623-8. PubMed ID: 396491
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Significance of the saralasin infusion test in the diagnosis of arterial hypertension].
    Glorioso N, Madeddu P, Dessì-Fulgheri P, Meloni F, Palermo M, Fiori C, Rappelli A.
    Boll Soc Ital Cardiol; 1980 Oct; 25(9):1035-46. PubMed ID: 7025868
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The saralasin test. Use in diagnosis of nephrovascular hypertension].
    Pigliucci GM, Falappa P, Martino F.
    Minerva Cardioangiol; 1979 Sep; 27(9):551-8. PubMed ID: 398451
    [No Abstract] [Full Text] [Related]

  • 14. Saralasin for diagnosis of renovascular hypertension.
    Med Lett Drugs Ther; 1982 Jan 08; 24(600):3-4. PubMed ID: 7054649
    [No Abstract] [Full Text] [Related]

  • 15. Use of saralasin in end-stage renal disease.
    Fadem SZ, Lifschitz MD.
    Kidney Int Suppl; 1979 Mar 08; (9):S93-100. PubMed ID: 289869
    [No Abstract] [Full Text] [Related]

  • 16. [Effect of saralasin on normal blood pressure and on reno-vascular hypertension (author's transl)].
    Beckerhoff R, Vetter W, Furrer J, Nussberger J, Schmied U, Siegenthaler W.
    Dtsch Med Wochenschr; 1976 Mar 12; 101(11):398-401. PubMed ID: 1253700
    [Abstract] [Full Text] [Related]

  • 17. [Therapeutic prospects in the use of saralasin].
    Pigliucci GM, Valenza M, Rosati F, Cagossi M.
    Chir Patol Sper; 1979 Oct 12; 27(5):491-7. PubMed ID: 261945
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Angiotensin blockade by saralasin bolus injection.
    Maxwell MH, Marks LS.
    Kidney Int Suppl; 1979 Mar 12; (9):S53-9. PubMed ID: 289864
    [No Abstract] [Full Text] [Related]

  • 20. [Saralasin test in the differential diagnosis of essential and renal hypertension].
    Scholze J, Matzke J, Homuth V, Frille J, Scholz D, Faulhaber HD, Engelhardt I, Hartrodt W, Naumann E, Buder HW.
    Z Urol Nephrol; 1986 Feb 12; 79(2):101-16. PubMed ID: 3518278
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 23.